MFDS — authorised 30 January 2009
- Marketing authorisation holder: TAKEDA PHARMS USA
- Status: likely_approved
🇰🇷 Dexilant in South Korea
MFDS authorised Dexilant on 30 January 2009
Marketing authorisation
Dexilant in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in South Korea
Frequently asked questions
Is Dexilant approved in South Korea?
Yes. MFDS authorised it on 30 January 2009.
Who is the marketing authorisation holder for Dexilant in South Korea?
TAKEDA PHARMS USA holds the South Korean marketing authorisation.